|
Health starts with the individual cells of our body. If our cells are healthy so are we. Healthy cells, in turn,
depend on the continued, faultless replication of our DNA. DNA can be seriously damaged through
attacks by free radicals so an adequate antioxidant status is essential to cell health. It is now becoming
clear though that antioxidants alone are not enough to protect our DNA; more and more research points to
the B vitamin folic acid as being equally or perhaps even more important in ensuring proper DNA
replication. It is not surprising that a folic acid deficiency has been implicated in a wide variety of disorders
from Alzheimer's disease to atherosclerosis, heart attack, stroke, osteoporosis, cervical and colon cancer,
depression, dementia, cleft lip and palate, hearing loss, and of course, neural tube defects. The list of
conditions involving a folic acid deficiency is growing day-by-day, as is clinical evidence that most of these
conditions can be reversed by supplementation.
Folic acid (folinic acid, folacin, pteroylglutamic acid) was first isolated from spinach leaves (its name
derives from the Latin folium meaning "leaf") in 1964 and early on was found to be essential in the
prevention of anemia in animals. Later it was discovered that ensuring that mothers had adequate folic
acid levels could prevent neural tube defects in human babies.
Folic acid is essential for the synthesis of adenine and thymine, two of the four nucleic acids that make up
our genes, DNA and chromosomes. It is now also clear that folic acid is required for the proper
metabolism of the essential amino acid methionine that is found primarily in animal proteins. Methionine
is converted to homocysteine in the body. Homocysteine, in turn, may be converted back to methionine in
a process requiring folic acid (tetrahydrofolate) and vitamin-B12 (cobalamin) as a catalyst or it may be
metabolized into cysteine in a process catalyzed by vitamin-B6 (pyridoxine). Cysteine is a vital link in the
synthesis of glutathione, one of our most important antioxidants. A high blood level of homocysteine has
been found to be highly detrimental to health and is invariably accompanied by a low level of folic
acid(1,2).
Homocysteine and heart disease
The idea that homocysteine may be a potent risk factor for coronary heart disease (CAD) was first
advanced in 1986(3). Since then numerous studies have confirmed that high homocysteine levels not
only increase the risk of CAD, but also increase the risk of heart attacks, strokes, and peripheral vascular
disease (e.g. intermittent claudication)(2,4-12). The average blood level of homocysteine in adults is
about 10 micromol/L. Men with a level of 15 micromol/L increase their risk for CAD by 60 per cent and
women by 80 per cent. The risk of a stroke at the 15 micromol/L level is two to five times higher than at
the 10 micromol/L level in both men and women and the risk of peripheral vascular disease is seven times
higher among people with elevated levels(5). Researchers at the Harvard Medical School report that a
homocysteine level of more than 11.2 micromol/L confers a five-fold increase in heart attack risk as
compared to the risk at 7.2 micromol/L or less(9).
There is rare, unanimous consent within the medical community that homocysteine levels in North
America are too high. One study estimates that 56,000 lives could be saved every year if average levels
could be lowered by just 5 micromol/L(10,11). Fortunately, lowering your homocysteine level is simple by
supplementing with folic acid and vitamins B12 and B6(2,4,5,9-13). Although most research into the
harmful effects of homocysteine has centered on heart disease there is growing evidence that high
homocysteine levels (or low folate levels) are involved in many other disorders.
Folic acid protects the brain
A low or deficient blood level of folate (folic acid) has been detected in 15 to 38 per cent of adults suffering
from depression. There is now increasing evidence that supplementation with therapeutic amounts of
folate can significantly improve the condition of depressed patients. In a recent trial involving 20 elderly
patients with depressive disorders, treatment with 50 mg/day of methylfolate was associated with an 81
per cent response rate within six weeks. Folate supplementation (15 mg/day of methylfolate) has also
been found to markedly improve the effect of treatment with standard antidepressants. Researchers at
the Harvard Medical School point out that chronic diseases (e.g. rheumatoid arthritis), certain cancer
treatments, alcoholism, and a poor diet can all lead to a folate deficiency and the potential for
depression(14,15).
Research has also shown that many drugs such as methotrexate, levopoda, niacin, phenytoin (Dilantin),
carbamazepine, and theophylline can markedly reduce folate levels(2,10,11). Researchers at Oxford
University recently reported that Alzheimer's patients have substantially lower levels of folic acid and
vitamin B12 than do normal people of the same age. They also found that a high homocysteine level is a
potent risk factor for AD; study participants with a level above 14 micromol/L had an almost five times
higher risk than participants with levels below 11 micromol/L. Participants with low folate and vitamin B12
levels had a three to four times higher risk of AD than did people with normal levels(16).
Folic acid is especially important for women
It is now firmly established that women can reduce their risk of giving birth to a baby with neural tube
defects (e.g. spina bifida) by supplementing with folic acid prior to conception and during
pregnancy(10,11,17). Perhaps less well known is the finding that women can also markedly reduce their
risk of giving birth to a child with a cleft lip or palate by supplementing daily with a multivitamin containing
0.4 to 0.8 mg of folic acid(18). These findings are particularly important in view of the fact that oral
contraceptives reduce folate levels significantly. Women who have been "on the pill" need to boost their
folate status if they are planning a pregnancy(19-21).
Low folate levels are also heavily implicated in the development of cervical cancer. Cervical dysplasia is
the precursor of cervical cancer and is usually first detected through a routine Pap smear. Fortunately,
folate supplementation (0.8-3.0 mg/day) is very effective in reversing cervical dysplasia and preventing the
cancer(22-24). Researchers at the Harvard Medical School recently reported that women who
supplemented with folic acid (0.4 mg/day or more for at least 15 years) had a four times lower risk of
developing colon cancer than did women with a daily intake of 0.2 mg/day or less (the daily contribution of
a typical North American diet)(25-27). Many postmenopausal women have increased homocysteine levels
that are believed to contribute to the risk of osteoporosis; folate supplementation can reverse these high
levels(28).
And the list goes on
There is no question that folic acid is extremely important to health and wellbeing. Not only is it important
for heart health, mental health and women's health, but it is now also clear that it affects many other facets
of health and disease. Researchers at the Cleveland Clinic Foundation have found that patients with end-
stage renal disease have extremely high homocysteine levels and can be protected from cardiovascular
events by supplementing with folic acid, vitamins B6 and B12(29). Diabetes patients tend to have high
homocysteine levels and folate is especially important for them(30). Recent research has also shown that
low folate levels (high homocysteine levels) are implicated in age-related hearing loss, psoriasis, and
restless leg syndrome(31-33).
It is indeed astounding that one single vitamin, folic acid, can have such a profound effect on our health
and yet perhaps it is not so surprising when one considers its vital role in DNA synthesis and
homocysteine metabolism.
So how much is enough
It is estimated that 88 per cent of all North Americans suffer from a folate deficiency(5,8). Obviously, the
standard diet is not supplying what we need. This has led to the fortification of cereals and other
foodstuffs with folic acid to try to ensure a minimum daily intake of 0.4 mg/day. Although beans and green
vegetables like spinach and kale are good sources of folates, relatively few people eat lots of vegetables
and cooking destroys most of the folate anyway(8). Realizing the poor availability from the diet many
medical researchers now advocate daily supplementation with folic acid. Because folic acid needs the
catalysts vitamins B12 and B6 to carry out its functions effectively it is usual to supplement with a
combination of the three. Dosage recommendations for folic acid vary between 0.4 mg/day and 10
mg/day or more depending on the severity of the deficiency and the health problem to be overcome. The
RDA for adults is now 0.4 mg/day and 0.6 mg/day for pregnant women. Recommendations for vitamin
B12 generally range from 0.5 to 1.0 mg/day and for vitamin-B6 from 10 to 250
mg/day(2,4,5,9,10,11,13,34-36).
Supplementation with folic acid and vitamins B6 and B12 costs only pennies a day and yet it is indeed
hard to imagine a better investment in protecting your health.
REFERENCES
- Lehninger, Albert L. Biochemistry, 2nd edition, 1975, NY, Worth Publishers Inc., pp. 345-7
- Moustapha, Ali and Robinson, Killian. Homocysteine: an emerging age-related cardiovascular risk
factor. Geratrics, Vol. 54, April 1999, pp. 41-51
- Kang, S.S., et al. Protein-bound homocysteine. A possible risk factor for coronary artery disease. J.
Clin. Invest., Vol. 77, 1986, pp. 1482-86
- Stampfer, Meir, J. and Malinow, M. Rene. Can lowering homocysteine levels reduce cardiovascular
risk? New England Journal of Medicine, Vol. 332, February 2, 1995, pp. 328-29
- Boushey, Carol J., et al. A quantitative assessment of plasma homocysteine as a risk factor for
vascular disease. Journal of the American Medical Association, Vol. 274, October 4, 1995, pp. 1049-
57
- Nygard, Ottar, et al. Total plasma homocysteine and cardiovascular risk profile. Journal of the
American Medical Association, Vol. 274, November 15, 1995, pp. 1526-33
- Perry, I.J., et al. Prospective study of serum total homocysteine concentration and risk of stroke in
middle-aged British men. The Lancet, Vol. 346, November 25, 1995, pp. 1395-98
- Morrison, Howard I., et al. Serum folate and risk of fatal coronary heart disease. Journal of the
American Medical Association, Vol. 275, June 26, 1996, pp. 1893-96
- Verhoef, Petra, et al. Homocysteine metabolism and risk of myocardial infarction: relation with
vitamins B-6, B-12, and folate. American Journal of Epidemiology, Vol. 143, May 1, 1996, pp. 845-59
- Moghadasian, Mohammed H., et al. Homocysteine and coronary artery disease. Archives of
Internal Medicine, Vol. 157, November 10, 1997, pp. 2299-2308
- Fallest-Strobl, Patricia C., et al. Homocysteine: a new risk factor for atherosclerosis. American
Family Physician, Vol. 56, October 15, 1997, pp. 1607-12
- Rimm, Eric B., et al. Folate and vitamin B-6 from diet and supplements in relation to risk of coronary
heart disease among women. Journal of the American Medical Association, Vol. 279, February 4,
1998, pp. 359-64 and pp. 392-93 (editorial)
- Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials.
British Medical Journal, Vol. 316, March 21, 1998, pp. 894-98
- Alpert, Jonathan E. and Fava, Maurizio. Nutrition and depression: the role of folate. Nutrition
Reviews, Vol. 55, May 1997, pp. 145-49
- Ebly, Erika M., et al. Folate status, vascular disease and cognition in elderly Canadians. Age and
Ageing, Vol. 27, July 1998, pp. 485-91
- Clarke, Robert, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer
disease. Archives of Neurology, Vol. 55, November 1998, pp. 1449-55 and pp. 1407-08 (editorial)
- Palca, Joseph. Agencies split on nutrition advice. Science, Vol. 257, September 25, 1992, p. 1857
- Shaw, Gary M., et al. Risks of orofacial clefts in children born to women using multivitamins containing
folic acid periconceptionally. The Lancet, Vol. 346, August 12, 1995, pp. 393-96
- Shojania, A.M. Oral contraceptives: effect of folate and vitamin B12 metabolism. Canadian Medical
Association Journal, Vol. 126, No. 3, February 1, 1982, pp. 244-47
- Martinez, O. and Roe, D.A. Effect of oral contraceptives on blood folate levels in pregnancy.
American Journal of Obstetrics and Gynecology, Vol. 128, No. 3, June 1, 1977, pp. 255-61
- Pietarinen, G.J., et al. Dietary folate intake and concentration of folate in serum and erythrocytes in
women using oral contraceptives. American Journal of Clinical Nutrition, Vol. 30, March 1977, pp.
375-80
- Murray, Michael T. Encyclopedia of Nutritional Supplements, 1996, Rocklin, CA, Prima Publishing,
p. 124
- Passwater, Richard A. Cancer Prevention and Nutritional Therapies, 1993, New Canaan, CT,
Keats Publishing Inc., p. 182
- Butterworth, Charles E., Jr., et al. Folate-induced regression of cervical intraepithelial neoplasia in
users of oral contraceptive agents. American Journal of Clinical Nutrition, Vol. 33, 1980, p. 926
- Giovannucci, Edward, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health
Study. Annals of Internal Medicine, Vol. 129, October 1, 1998, pp. 517-24
- Kim, Young-In, et al. Colonic mucosal concentrations of folate correlate well with blood measurements
of folate status in persons with colorectal polyps. American Journal of Clinical Nutrition, Vol. 68,
October 1998, pp. 866-72 and pp. 763-64 (editorial)
- Kato, I., et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control
study. British Journal of Cancer, Vol. 79, No. 11/12, April 1999, pp. 1917-21
- Murray, Michael T. Encyclopedia of Nutritional Supplements, 1996, Rocklin, CA, Prima Publishing,
pp. 123-24
- Robinson, Killian, et al. Hyperhomocysteinemia confers an independent increased risk of
atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine
concentrations. Circulation, Vol. 94, No. 11, December 1, 1996, pp. 2743-48
- Hultberg, B., et al. Poor metabolic control, early age at onset, marginal folate deficiency are
associated with increasing levels of plasma homocysteine in insulin-dependent diabetes mellitus. Scand.
J. Clin. Lab. Invest., Vol. 57, No. 7, November 1997, pp. 595-600
- Houston, Denise K., et al. Age-related hearing loss, vitamin B-12, and folate in elderly women.
American Journal of Clinical Nutrition, Vol. 69, March 1999, pp. 564-71
- Fry, L., et al. The mechanism of folate deficiency in psoriasis. British Journal of Dermatology, Vol.
84, June 1971, pp. 539-44
- Rona, Zoltan. Return to the Joy of Health, 1995, Vancouver, BC, Alive Books, p. 193
- Bailey, Lynn B. Dietary reference intake for folate: the debut of dietary folate equivalents. Nutrition
Reviews, Vol. 56, October 1998, pp. 294-99
- Bronstrup, Anja, et al. Effects of folic acid and combinations of folic acid and vitamin B-12 on plasma
homocysteine concentrations in healthy, young women. American Journal of Clinical Nutrition, Vol. 68,
November 1998, pp. 1104-10
- Brouwer, Ingeborg A., et al. Low-dose folic acid supplementation decreases plasma homocysteine
concentrations: a randomized trial. American Journal of Clinical Nutrition, Vol. 69, January 1999, pp.
99-104
|
|